Who founded Convergentrx?

Convergentrx was founded by Philip Kantoff, Neil Bander in 2021.

Who are Convergentrx's investors?

Convergentrx's investors include OrbiMed.

Convergentrx

Founded 2021 · 41 employees on LinkedIn · 1 known investors

Convergent Therapeutics develops radioantibody-based (PSMA-targeted) therapies for cancers, including metastatic castration-resistant prostate cancer (mCRPC). The clinical-stage biotech is advancing radiopharmaceutical treatments backed by preclinical and clinical data.

Biotech Healthtech

Founders & leadership

Convergentrx was founded in 2021 by Philip Kantoff and Neil Bander.

Philip KantoffinChief Executive Officer, Co-FounderExecutive Officer, Director at Convergent Therapeutics

Neil BanderSenior Scientific Advisor, Co-Founder

Alex BrowninChief Operating OfficerExecutive Officer at Convergent Therapeutics

Andrew DavisinChief Business and Strategy OfficerChief Business Officer at Dynavax NASDAQ: DVAX www.dynavax.com

Elizabeth L. MontgomeryinChief People Officer

Eric M. SullivaninChief Financial OfficerExecutive Officer at Convergent Therapeutics

Investors · 1

OrbiMedNew York · $1M – $75M

Frequently asked questions

What does Convergentrx do?: Convergent Therapeutics develops radioantibody-based (PSMA-targeted) therapies for cancers, including metastatic castration-resistant prostate cancer (mCRPC). The clinical-stage biotech is advancing radiopharmaceutical treatments backed by preclinical and clinical data.
Who founded Convergentrx?: Convergentrx was founded by Philip Kantoff, Neil Bander in 2021.
Who are Convergentrx's investors?: Convergentrx's investors include OrbiMed.